Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin‐10 on organ allograft and tumour rejection

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Immunology

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2567.2000.00096.xPMID 11012777PMCID PMC2327075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector.

  1999cited by this paper
• Recombinant adenovirus is an efficient and non‐perturbing genetic vector for human dendritic cells

  1999cited by this paper
• Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.

  1999cited by this paper
• Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.

  1999cited by this paper
• Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells.

  1999cited by this paper
• Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients

  1999cited by this paper
• Adenoviruses Activate Human Dendritic Cells without Polarization toward a T-Helper Type 1-Inducing Subset

  1999cited by this paper
• Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation.

  1998cited by this paper
• Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1.

  1998cited by this paper
• Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation.

  1998cited by this paper
• Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness.

  1998cited by this paper
• Induction of tolerance by IL-10-treated dendritic cells.

  1997cited by this paper
• Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.

  1997cited by this paper
• Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow.

  1997cited by this paper
• Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia

  1997cited by this paper
• Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.

  1996cited by this paper
• Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice.

  1996cited by this paper
• Interleukin-10 pre-treatment protects target cells from tumor- and allo-specific cytotoxic T cells and down-regulates HLA class I expression

  1996cited by this paper
• Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.

  1996cited by this paper
• Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis.

  1996cited by this paper
• GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival

  1995cited by this paper
• Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony- stimulating factor

  1995cited by this paper
• Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival.

  1995cited by this paper
• Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes.

  1995cited by this paper
• IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.

  1995cited by this paper
• Propagation of dendritic cell progenitors from normal mouse liver using GM-CSF and their maturational development in the presence of type-I collagen

  1994cited by this paper
• Interleukin 10 pretreatment protects target cells from tumor- and allo- specific cytotoxic T cells and downregulates HLA class I expression

  1994cited by this paper
• Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen

  1994cited by this paper
• Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon 3,-Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Synthesis in Accessory Cells By Annalisa D'Andrea, Miguel Aste-Amezaga,

  1993cited by this paper
• Immunology of heart and lung transplantation

  1993cited by this paper
• The Cytokine Handbook

  1993cited by this paper
• Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.

  1993cited by this paper
• Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

  1993cited by this paper
• Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.

  1993cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.

  1992cited by this paper
• Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures.

  1992cited by this paper
• The dendritic cell system and its role in immunogenicity.

  1991cited by this paper
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

  1991cited by this paper
• IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

  1991cited by this paper
• Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

  1990cited by this paper
• Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

  1989cited by this paper
• Improved technique of heart transplantation in rats.

  1969cited by this paper

• Immunoregulatory iPSC-derived non-lymphoid progeny in autoimmunity and GVHD alloimmunity.

  2025cites this paper
• Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans

  2022cites this paper
• Transcriptomic Analysis Identifies A Tolerogenic Dendritic Cell Signature

  2021cites this paper
• Effect of immune tolerance induced by immature dendritic cells and CTLA4-Ig on systemic lupus erythematosus: An in vivo study.

  2018cites this paper
• Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity

  2017cites this paper
• Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man

  2015cites this paper
• Overexpression of Jagged‐1 combined with blockade of CD40 pathway prolongs allograft survival

  2015cites this paper
• Dendritic Cell-Based Approaches for Therapeutic Immune Regulation in Solid-Organ Transplantation

  2013cites this paper
• Tolerogenic dendritic cells and their potential applications

  2011cites this paper
• Induction of donor-specific T cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models

  2009cites this paper
• Programmed Death-1 Signaling Is Essential for the Skin Allograft Protection by Alternatively Activated Dendritic Cell Infusion in Mice

  2009cites this paper
• Induction of Donor-Specific T-Cell Hyporesponsiveness Using Dexamethasone-Treated Dendritic Cells in Two Fully Mismatched Rat Kidney Transplantation Models

  2008cites this paper
• MANIPULATION OF DENDRITIC CELL MIGRATION AND FUNCTION IN RELATION TO ALLOIMMUNE REACTIVITY AND TRANSPLANT OUTCOME

  2006cites this paper
• “Alternatively Activated” Dendritic Cells Preferentially Secrete IL-10, Expand Foxp3+CD4+ T Cells, and Induce Long-Term Organ Allograft Survival in Combination with CTLA4-Ig1

  2006cites this paper
• CTLA 4-Ig Allograft Survival in Combination with T Cells , and Induce Long-Term Organ + CD 4 + Preferentially Secrete IL-10 , Expand Foxp 3 ' ' Alternatively Activated ' ' Dendritic Cells

  2006cites this paper
• Marked Prolongation of Murine Cardiac Allograft Survival Using Recipient Immature Dendritic Cells Loaded with Donor‐Derived Apoptotic Cells

  2004cites this paper
• RAPAMYCIN PROTECTS ALLOGRAFTS FROM REJECTION WHILE SIMULTANEOUSLY ATTACKING TUMORS IN IMMUNOSUPPRESSED MICE

  2004cites this paper
• Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival

  2004cites this paper
• IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.

  2004cites this paper
• Unexpected effects of viral interleukin-10-secreting dendritic cells in vivo: preferential inhibition of TH2 responses.

  2004cites this paper
• Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10-producing CD4+ T cells.

  2004cites this paper
• Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin

  2003cites this paper
• Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection

  2003cites this paper
• Gene Therapy Progress and Prospects: Gene therapy in organ transplantation

  2003cites this paper
• TGF-β1-conditioned glial cell-derived dendritic cells inhibit expansion of MBP-reactive T cells in vitro

  2002cites this paper
• TGF-beta1-conditioned glial cell-derived dendritic cells inhibit expansion of MBP-reactive T cells in vitro.

  2002cites this paper
• TGF-β1 synergizes with GM-CSF to promote the generation of glial cell-derived dendriform cells in vitro

  2002cites this paper
• Adenoviral Vectors Encoding CTLA 4-Ig Oligodeoxyribonucleotide Decoys and B κ Engineered with NF-Survival by Dendritic Cells Genetically Marked Prolongation of Cardiac Allograft and

  2002cites this paper
• Marked Prolongation of Cardiac Allograft Survival by Dendritic Cells Genetically Engineered with NF-κB Oligodeoxyribonucleotide Decoys and Adenoviral Vectors Encoding CTLA4-Ig1

  2002cites this paper
• Dendritic cells exposed in vitro to TGF‐β1 ameliorate experimental autoimmune myasthenia gravis

  2002cites this paper
• Gene therapy and graft modification

  2001cites this paper
• Potential of tolerogenic dendritic cells for transplantation.

  2001cites this paper
• CHAPTER 43 – Genetic engineering of dendritic cells

  2001cites this paper